Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor–Positive Metastatic Breast Cancer

PURPOSE: Frequent neutropenia hinders uninterrupted palbociclib treatment in patients with hormone receptor (HR)–positive breast cancer. We compared the efficacy outcomes in multicenter cohorts of patients with metastatic breast cancer (mBC) receiving palbociclib following conventional dose modifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seul-Gi, Kim, Min Hwan, Park, Sejung, Kim, Gun Min, Kim, Jee Hung, Kim, Jee Ye, Park, Hyung Seok, Park, Seho, Park, Byeong Woo, Kim, Seung Il, Ji, Jung Hwan, Jeong, Joon, Shin, Kabsoo, Lee, Jieun, Kim, Hyung-Don, Jung, Kyung Hae, Sohn, Joohyuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582537/
https://www.ncbi.nlm.nih.gov/pubmed/37054718
http://dx.doi.org/10.4143/crt.2022.1543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582537/
https://www.ncbi.nlm.nih.gov/pubmed/37054718
http://dx.doi.org/10.4143/crt.2022.1543

Ejemplares similares